That is lots of stuff to study through.
In any case "
Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals for Above 55 Years Old"
is far from your claim of "The weakness of inactivated is little or no CD8+ killer T cell response."
The other thing is the study is on 2 doses of CoronaVac. The Sinovac/Sinopharm is really a 3-dose vaccine from what we have seen with the Hong Kong University Study. The advantage of the inactivated vaccines in having much more antigen sites (in regard to virus mutation) still holds.
As with any vaccine, one has to weigh the effectiveness against the side effects as well.